Ricci, Claudio; Campana, Davide; Ingaldi, Carlo; Lamberti, Giuseppe; Alberici, Laura; Tateo, Valentina; Castagna, Giovanni; Ricco, Gianluca; Calderaro, Fulvio; Malvi, Deborah; Rosini, Francesca; Casadei, Riccardo, Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis, «LANGENBECK'S ARCHIVES OF SURGERY», 2023, 408, Article number: 65, pp. 1 - 7 [articolo]Open Access
Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; Lamberti G., BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature, «ANTI-CANCER DRUGS», 2023, 34, pp. 1076 - 1084 [articolo]
Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Maria Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA, Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review, «JOURNAL OF CLINICAL MEDICINE», 2023, 12, Article number: 717, pp. 1 - 19 [articolo]Open Access
Thummalapalli R.; Ricciuti B.; Bandlamudi C.; Muldoon D.; Rizvi H.; Elkrief A.; Luo J.; Alessi J.V.; Pecci F.; Lamberti G.; Di Federico A.; Hong L.; Zhang J.; Heymach J.V.; Gibbons D.L.; Plodkowski A.J.; Ravichandran V.; Donoghue M.T.A.; Vanderbilt C.; Ladanyi M.; Rudin C.M.; Kris M.G.; Riely G.J.; Chaft J.E.; Hellmann M.D.; Vokes N.I.; Awad M.M.; Schoenfeld A.J., Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer, «CLINICAL CANCER RESEARCH», 2023, 29, pp. 4408 - 4418 [articolo]Open Access
Alessi J.V.; Elkrief A.; Ricciuti B.; Wang X.; Cortellini A.; Vaz V.R.; Lamberti G.; Frias R.L.; Venkatraman D.; Fulgenzi C.A.M.; Pecci F.; Recondo G.; Di Federico A.; Barrichello A.; Park H.; Nishino M.; Hambelton G.M.; Egger J.V.; Ladanyi M.; Digumarthy S.; Johnson B.E.; Christiani D.C.; Lin X.; Gainor J.F.; Lin J.J.; Pinato D.J.; Schoenfeld A.J.; Awad M.M., Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC, «JOURNAL OF THORACIC ONCOLOGY», 2023, 18, pp. 731 - 743 [articolo]
Scalera S.; Ricciuti B.; Mazzotta M.; Calonaci N.; Alessi J.V.; Cipriani L.; Bon G.; Messina B.; Lamberti G.; Di Federico A.; Pecci F.; Milite S.; Krasniqi E.; Barba M.; Vici P.; Vecchione A.; De Nicola F.; Ciuffreda L.; Goeman F.; Fanciulli M.; Buglioni S.; Pescarmona E.; Sharma B.; Felt K.D.; Lindsay J.; Rodig S.J.; De Maria R.; Caravagna G.; Cappuzzo F.; Ciliberto G.; Awad M.M.; Maugeri-Sacca M., Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma, «ANNALS OF ONCOLOGY», 2023, 34, pp. 275 - 288 [articolo]
Negrao, M. V.; Araujo, H. A.; Lamberti, G.; Cooper, A. J.; Akhave, N. S.; Zhou, T.; Delasos, L.; Hicks, J. K.; Aldea, M.; Minuti, G.; Hines, J.; Aredo, J. V.; Dennis, M. J.; Chakrabarti, T.; Scott, S. C.; Bironzo, P.; Scheffler, M.; Christopoulos, P.; Stenzinger, A.; Riess, J. W.; Kim, S. Y.; Goldberg, S. B.; Li, M.; Wang, Q.; Qing, Y.; Ni, Y.; Do, M. T.; Lee, R.; Ricciuti, B.; Alessi, J. V.; Wang, J.; Resuli, B.; Landi, L.; Tseng, S. -C.; Nishino, M.; Digumarthy, S. R.; Rinsurongkawong, W.; Rinsurongkawong, V.; Vaporciyan, A. A.; Blumenschein, G. R.; Zhang, J.; Owen, D. H.; Blakely, C. M.; Mountzios, G.; Shu, C. A.; Bestvina, C. M.; Garassino, M. C.; Marrone, K. A.; Gray, J. E.; Patel, S. P.; Cummings, A. L.; Wakelee, H. A.; Wolf, J.; Scagliotti, G. V.; Cappuzzo, F.; Barlesi, F.; Patil, P. D.; Drusbosky, L.; Gibbons, D. L.; Meric-Bernstam, F.; Lee, J. J.; Heymach, J. V.; Hong, D. S.; Heist, R. S.; Awad, M. M.; Skoulidis, F., Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC, «CANCER DISCOVERY», 2023, 13, pp. 1556 - 1571 [articolo]Open Access
Elkrief A.; Alessi J.M.V.; Ricciuti B.; Brown S.; Rizvi H.; Preeshagul I.R.; Wang X.; Pecci F.; Di Federico A.; Lamberti G.; Egger J.V.; Chaft J.E.; Rudin C.M.; Riely G.J.; Kris M.G.; Ladanyi M.; Chen Y.; Hellmann M.D.; Shen R.; Awad M.M.; Schoenfeld A.J., Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2023, 11, Article number: e006994, pp. 1 - 11 [articolo]Open Access
Stumpo S.; Formelli M.G.; Persano I.; Parlagreco E.; Lauricella E.; Rodriquenz M.G.; Guerrera L.P.; Zurlo I.V.; Campana D.; Brizzi M.P.; Cives M.; La Salvia A.; Lamberti G., Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives, «JOURNAL OF CLINICAL MEDICINE», 2023, 12, Article number: 7715, pp. 1 - 25 [articolo]Open Access
Alessi J.V.; Wang X.; Elkrief A.; Ricciuti B.; Li Y.Y.; Gupta H.; Spurr L.F.; Rizvi H.; Luo J.; Pecci F.; Lamberti G.; Recondo G.; Venkatraman D.; Di Federico A.; Gandhi M.M.; Vaz V.R.; Nishino M.; Sholl L.M.; Cherniack A.D.; Ladanyi M.; Price A.; Richards A.L.; Donoghue M.; Lindsay J.; Sharma B.; Turner M.M.; Pfaff K.L.; Felt K.D.; Rodig S.J.; Lin X.; Meyerson M.L.; Johnson B.E.; Christiani D.C.; Schoenfeld A.J.; Awad M.M., Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC, «JOURNAL OF THORACIC ONCOLOGY», 2023, 18, pp. 1524 - 1537 [articolo]
Alessi J.V.; Ricciuti B.; Wang X.; Pecci F.; Di Federico A.; Lamberti G.; Elkrief A.; Rodig S.J.; Lebow E.S.; Eicholz J.E.; Thor M.; Rimner A.; Schoenfeld A.J.; Chaft J.E.; Johnson B.E.; Gomez D.R.; Awad M.M.; Shaverdian N., Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC, «NATURE COMMUNICATIONS», 2023, 14, Article number: 4238, pp. 1 - 12 [articolo]Open Access
Moliner, Laura; Zhang, Bingnan; Lamberti, Giuseppe; Ardizzoni, Andrea; Byers, Lauren A.; Califano, Raffaele, Novel therapeutic strategies for recurrent SCLC, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2023, 186, Article number: 104017, pp. 1 - 9 [articolo]
Lamberti, Giuseppe; Andrini, Elisa; Ricci, Claudio; Campana, Davide, Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm, «THE LANCET ONCOLOGY», 2023, 24, pp. e187 - e187 [articolo]
Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; Hellmann, M. D.; Kris, M. G.; Arcila, M. E.; Baine, M. K.; Rudin, C. M.; Lito, P.; Ladanyi, M.; Schoenfeld, A. J.; Riely, G. J.; Awad, M. M.; Arbour, K. C., Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12CMutant Non-Small Cell Lung Cancer, «THE ONCOLOGIST», 2023, 28, pp. 978 - 985 [articolo]Open Access
Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lamberti G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M., Peripheral nervous system adverse events associated with immune checkpoint inhibitors, «JOURNAL OF NEUROLOGY», 2023, 270, pp. 2975 - 2986 [articolo]Open Access
